Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged.
Trending
- Pixar’s Gatto Trailer Teases Mark Ruffalo In Mobster Cat Movie
- For Spielberg, aliens are not just fiction
- The week in pictures: World Cup 2026 kicks off, the Pope visits Spain and the White House prepares for a cage fight showdown
- The Big Destination Show Debrief
- Fringes are back, but not as you know them
- ‘Disclosure Day’ tops North American box office in $44m bow; ‘Obsession’ nears $200m | News
- Kings Of Indigo: Lente/Zomer 2027-collectie
- ‘Hear The Yellow’ Sweeps Board
